Limestone Health, LLC

Limestone Health, LLC focuses on providing comprehensive treatment solutions for opioid addiction, employing a range of effective strategies to support recovery and enhance patient engagement through medication-assisted treatment and counseling services. Founded in 2018 and headquartered in Bloomington, US, Limestone Health, LLC specializes in opioid addiction treatment. The company was acquired in November 2020 by BayMark Health Services Inc. , along with related entities.

The acquisition was aimed at expanding capabilities in addressing opioid dependency. The founder's details are not provided. Limestone Health, LLC offers a variety of services for opioid addiction treatment, including medication-assisted treatment (MAT), substance use counseling, and supplemental support services. MAT minimizes cravings and withdrawal symptoms, while counseling addresses the underlying causes of substance use, providing individuals with coping strategies.

The company operates treatment centers in states such as California, Florida, Texas, and Ohio, ensuring accessibility for clients seeking recovery. Limestone Health, LLC generates revenue primarily through service fees charged to patients for their treatment programs. These services encompass outpatient treatment and counseling sessions. Patients engage in various treatment plans that typically involve ongoing medication and counseling, contributing to a recurring revenue stream for the company.

The pricing model reflects the comprehensive nature of its offerings, facilitating transactions that support both individual recovery and the financial viability of the treatment centers. Following its acquisition in November 2020, Limestone Health, LLC is positioned for growth through the support of BayMark Health Services Inc. While specific upcoming products have not been detailed, the growth strategy includes potential expansions into new markets and geographic regions aimed at increasing service accessibility. The recent acquisition funding will play a pivotal role in these expansion initiatives, enhancing operational capabilities and outreach efforts.